A method for the generation of single contracting human-induced pluripotent stem cell-derived cardiomyocytes

Circulation Research

Volumn 117, Issue 12, 2015, Pages 995-1000

  Feaster, Tromondae K ^a   Cadar, Adrian G ^d   Wang, Lili ^c   Williams, Charles H ^e   Chun, Young Wook ^c   Hempel, Jonathan E ^c   Bloodworth, Nathaniel ^f   Merryman, W David ^f   Lim, Chee Chew ^b   Wu, Joseph C ^h   Knollmann, Björn C ^c   Hong, Charles C ^b,g  

^a Departments of Pharmacology   (United States)

^b Division of Cardiovascular Medicine   (United States)

^c Oates Institute for Experimental Therapeutics   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Departments of Cell and Developmental Biology   (United States)

^f VANDERBILT UNIVERSITY   (United States)

^g Research Medicine   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac; Excitation contraction coupling; Matrigel; Myocytes; Pluripotent stem cells; Stem cells

Indexed keywords

5 [1 (3,4 DIMETHOXYBENZOYL) 1,2,3,4 TETRAHYDRO 6 QUINOLYL] 3,6 DIHYDRO 6 METHYL 2H 1,3,4 THIADIAZIN 2 ONE; CAFFEINE; MATRIGEL; TROPONIN I; COLLAGEN; DRUG COMBINATION; LAMININ; PROTEOGLYCAN;

ACTION POTENTIAL; ADULT; ANIMAL CELL; ARTICLE; CELL ELONGATION; CELL ISOLATION; CELL LEVEL; CELL SHAPE; CELL SIZE; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRESERVATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN- NDUCED PLURIPOTENT STEM CELL DERIVED CARDIAC MYOCYTE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SARCOMERE LENGTH; SODIUM CURRENT; WESTERN BLOTTING; YOUNG MODULUS; CARDIAC MUSCLE CELL; CELL CULTURE; CELL DIFFERENTIATION; DRUG COMBINATION; DRUG EFFECTS; HEART CONTRACTION; INDUCED PLURIPOTENT STEM CELL; PHYSIOLOGY;

CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LAMININ; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; PROTEOGLYCANS;

EID: 84952629037     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.307580     Document Type: Article

References (23)

1. Hayakawa T, Kunihiro T, Ando T, Kobayashi S, Matsui E, Yada H, Kanda Y, Kurokawa J, Furukawa T. Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: correlation and complementarity with extracellular electrophysiology. J Mol Cell Cardiol. 2014; 77: 178-191. doi: 10.1016/j.yjmcc.2014.09.010.
2. Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, Plews JR, Abilez OJ, Cui B, Gold JD, Wu JC. Chemically defined generation of human cardiomyocytes. Nat Methods. 2014; 11: 855-860. doi: 10.1038/nmeth.2999.
3. Hwang HS, Kryshtal DO, Feaster TK, Sanchez-Freire V, Zhang J, Kamp TJ, Hong CC, Wu JC, Knollmann BC. Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories. J Mol Cell Cardiol. 2015; 85: 79-88. doi: 10.1016/j.yjmcc.2015.05.003.
4. Rodriguez ML, Graham BT, Pabon LM, Han SJ, Murry CE, Sniadecki NJ. Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts. J Biomech Eng. 2014; 136: 051005. doi: 10.1115/1.4027145.
5. Ahola A, Kiviaho AL, Larsson K, Honkanen M, Aalto-Setala K, Hyttinen J. Video image-based analysis of single human induced pluripotent stem cell derived cardiomyocyte beating dynamics using digital image correlation. Biomed Eng Online. 2014; 13: 39. doi: 10.1186/1475-925X-13-39.
6. Liu J, Sun N, Bruce MA, Wu JC, Butte MJ. Atomic force mechanobiology of pluripotent stem cell-derived cardiomyocytes. PLoS One. 2012; 7: e37559. doi: 10.1371/journal.pone.0037559.
7. Hazeltine LB, Simmons CS, Salick MR, Lian X, Badur MG, Han W, Delgado SM, Wakatsuki T, Crone WC, Pruitt BL, Palecek SP. Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells. Int J Cell Biol. 2012; 2012: 508294. doi: 10.1155/2012/508294.
8. Agarwal A, Goss JA, Cho A, McCain ML, Parker KK. Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip. 2013; 13: 3599-3608. doi: 10.1039/c3lc50350j.
9. Costa KD, Lee EJ, Holmes JW. Creating alignment and anisotropy in engineered heart tissue: role of boundary conditions in a model three-dimensional culture system. Tissue Eng. 2003; 9: 567-577. doi: 10.1089/107632703768247278.
10. Stoehr A, Neuber C, Baldauf C, Vollert I, Friedrich FW, Flenner F, Carrier L, Eder A, Schaaf S, Hirt MN, Aksehirlioglu B, Tong CW, Moretti A, Eschenhagen T, Hansen A. Automated analysis of contractile force and Ca2+ transients in engineered heart tissue. Am J Physiol Heart Circ Physiol. 2014; 306: H1353-H1363. doi: 10.1152/ ajpheart.00705.2013.
11. Sharma A, Marceau C, Hamaguchi R, et al. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform. Circ Res. 2014; 115: 556-566. doi: 10.1161/CIRCRESAHA.115.303810.
12. Li X, Tsai P, Wieder ED, Kribben A, Van Putten V, Schrier RW, Nemenoff RA. Vascular smooth muscle cells grown on Matrigel. A model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J Biol Chem. 1994; 269: 19653-19658.
13. Chun YW, Balikov DA, Feaster TK, Williams CH, Sheng CC, Lee JB, Boire TC, Neely MD, Bellan LM, Ess KC, Bowman AB, Sung HJ, Hong CC. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes. Biomaterials. 2015; 67: 52-64. doi: 10.1016/j.biomaterials.2015.07.004.
14. Sanchez-Freire V, Lee AS, Hu S, Abilez OJ, Liang P, Lan F, Huber BC, Ong SG, Hong WX, Huang M, Wu JC. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. J Am Coll Cardiol. 2014; 64: 436-448. doi: 10.1016/j.jacc.2014.04.056.
15. Lundy SD, Zhu WZ, Regnier M, Laflamme MA. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 2013; 22: 1991-2002. doi: 10.1089/scd.2012.0490.
16. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002; 415: 198-205. doi: 10.1038/415198a.
17. Kuo PL, Lee H, Bray MA, Geisse NA, Huang YT, Adams WJ, Sheehy SP, Parker KK. Myocyte shape regulates lateral registry of sarcomeres and contractility. Am J Pathol. 2012; 181: 2030-2037. doi: 10.1016/j. ajpath.2012.08.045.
18. Bedada FB, Chan SS, Metzger SK, Zhang L, Zhang J, Garry DJ, Kamp TJ, Kyba M, Metzger JM. Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes. Stem Cell Reports. 2014; 3: 594-605. doi: 10.1016/j. stemcr.2014.07.012.
19. Lues I, Beier N, Jonas R, Klockow M, Haeusler G. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers. J Cardiovasc Pharmacol. 1993; 21: 883-892.
20. Stoehr A, Neuber C, Baldauf C, Vollert I, Friedrich FW, Flenner F, Carrier L, Eder A, Schaaf S, Hirt MN, Aksehirlioglu B, Tong CW, Moretti A, Eschenhagen T, Hansen A. Automated analysis of contractile force and Ca2+ transients in engineered heart tissue. Am J Physiol Heart Circ Physiol. 2014; 306: H1353-H1363. doi: 10.1152/ ajpheart.00705.2013.
21. Wang G, McCain ML, Yang L, et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med. 2014; 20: 616-623. doi: 10.1038/ nm.3545.
22. Knollmann BC, Knollmann-Ritschel BE, Weissman NJ, Jones LR, Morad M. Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. J Physiol. 2000; 525(Pt 2): 483-498.
23. Harmer AR, Abi-Gerges N, Morton MJ, Pullen GF, Valentin JP, Pollard CE. Validation of an in vitro contractility assay using canine ventricular myocytes. Toxicol Appl Pharmacol. 2012; 260: 162-172. doi: 10.1016/j.taap.2012.02.007.